Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
---|
08/31/2004 | US6784187 8-carboxamido-2,6-methano-3-benzazocines |
08/31/2004 | US6784173 Aromatic dicarboxylic acid derivatives |
08/31/2004 | US6783948 Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes |
08/26/2004 | WO2004072206A1 Organic electroluminescent device |
08/26/2004 | WO2004072074A1 Pyrrolidinohydrochinazolines |
08/26/2004 | WO2004072031A2 Phenylacetamides and their use as glucokinase modulators |
08/26/2004 | WO2004071382A2 Substituted heterocycles |
08/26/2004 | WO2004045562A3 Mixed kappa/mu opioids and uses thereof |
08/26/2004 | WO2004017922B1 Keto cannabinoids with therapeutic indications |
08/26/2004 | US20040167157 reacting a pyridinyl ketone with a halogenating agent in acetonitrile and dimethylformamide; hydrolysis, animation to get a 3-amino 4-halo pyridine; chemical intermediate; by-product inhibition |
08/26/2004 | US20040167145 moderator of cholinergic agent; mixture of acetylcholinesterase inhibitors and opioiod receptor blockers |
08/26/2004 | US20040167141 Anticancer agents; antidiabetic agents; Alzheimer's disease |
08/26/2004 | US20040167115 induction apoptosis; Dna replication inhibition; p38 MAP kinase activation or caspase cascading activation, or cytochromic C release from mitochondria into cytoplasm |
08/26/2004 | US20040167031 Arylphenyl-substituted cyclic ketoenols |
08/26/2004 | CA2515670A1 Phenylacetamides and their use as glucokinase modulators |
08/25/2004 | EP1449835A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds |
08/25/2004 | EP1448566A2 Chemokine receptor antagonists and methods of use thereof |
08/25/2004 | EP1448544A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
08/25/2004 | CN1523025A Method for producing pyridine derivatives |
08/25/2004 | CN1163495C Pyridine compounds, preparation method thereof and pharmaceutical compositions containing them |
08/25/2004 | CN1163224C Drugs for improving vesical excretory capacity |
08/24/2004 | US6781001 Extended rhodamine dye compound suitable for the creating of sets of spactrally resolvable fluorescent labels particlularly useful for fluorescence based dna sequencing system |
08/24/2004 | US6780997 Such as dibenzyl(a,3-o-isopropylidiene-3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl) hydroxymethylphosphonate which functions like pyridoxal-5'-phosphate in vivo; drug screening; antidiabetic agents |
08/24/2004 | US6780875 Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
08/24/2004 | US6780872 Asthma; antiepileptic agents; sexual disorders |
08/24/2004 | US6780868 Treatment of myocardial or peripheral ischaemia, cardiac insufficiency or pulmonary arterial hypertension |
08/19/2004 | WO2004069840A2 Production of tetrahydroquinoline benzofurans |
08/19/2004 | WO2004069829A1 (2s)-2-((pyrimidin-4-yl)amino)-4-methylpentanoic acid aminoethylamid derivatives as il-8 receptor modulators for the treatment of atherosclerosis and rheumatoid arthritis |
08/19/2004 | WO2004069824A1 Pyrazole derivative |
08/19/2004 | WO2004069813A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
08/19/2004 | WO2004069798A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
08/19/2004 | WO2004069792A2 Quinoline-derived amide modulators of vanilloid vr1 receptor |
08/19/2004 | WO2004069249A1 3-cyano-quinoline derivatives as non-receptor tyrosine kinase inhibitors |
08/19/2004 | WO2004069245A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents |
08/19/2004 | WO2004069197A2 Novel substituted 2,3-benzodiazepine derivatives |
08/19/2004 | WO2004058755A3 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors |
08/19/2004 | WO2004058720A3 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor |
08/19/2004 | WO2004029579A3 Fluorescent labeling reagents with multiple donors and acceptors |
08/19/2004 | WO2004009036A3 Compounds compositions and methods |
08/19/2004 | US20040162410 Thrombosis therapy; anticoagulants |
08/19/2004 | US20040162299 Substituted quinazolines and analogs and the use thereof |
08/19/2004 | DE10304950A1 Herstellung von Tetrahydrochinolinbenzofuranen Production of Tetrahydrochinolinbenzofuranen |
08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
08/19/2004 | CA2515119A1 Pyrazole derivative |
08/19/2004 | CA2514940A1 Quinoline-derived amide modulators of vanilloid vr1 receptor |
08/19/2004 | CA2514241A1 Oxazolidinone derivates n-substituted by a tricyclic ring, for use as antibacterial agents |
08/19/2004 | CA2513824A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
08/19/2004 | CA2512616A1 Novel substituted 2,3-benzodiazepine derivatives |
08/18/2004 | EP1446387A1 Substituted aryl 1,4-pyrazine derivatives |
08/18/2004 | EP1311487A4 Derivatives of 1,2-dihydro-7-hydroxyquinolines containing fused rings |
08/18/2004 | CN1522254A Immunomodulating compounds |
08/18/2004 | CN1522249A Quinoline derivatives as ligands for the neuropeptide y receptor |
08/18/2004 | CN1162433C Method for purifying tetrodotoxin |
08/18/2004 | CN1162432C 2,3-benzodiazepine derivatives |
08/18/2004 | CN1162428C Method for producing pyridine derivatives |
08/18/2004 | CN1162061C 10-hydroxy camptothecine, and method for processing raw material of camptothecine |
08/17/2004 | US6777555 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate |
08/17/2004 | US6777426 Imidazole and imidazoline derivatives and uses thereof |
08/17/2004 | US6777425 Which binds nucleic acids/dna; gene expression; genetic engineering |
08/17/2004 | US6777410 Isoindole derivatives |
08/17/2004 | US6777237 Bioconjugate comprises the bioactive agent and an organocobalt complex |
08/17/2004 | US6776976 Bioactive agent is covalently conjugated to an organocobalt complex's cobalt atom through a non-reactive atom in the bioactive agent molecule such as peptide, protein, nucleic acid and analogues |
08/12/2004 | WO2004067529A1 Indole-derivative modulators of steroid hormone nuclear receptors |
08/12/2004 | WO2004054504A3 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
08/12/2004 | WO2004052893A3 Substituted dihydropyrano indole-3,4-dione derivatives and 3-oxoacetic acid substituted 2-hydroxymethylindole derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
08/12/2004 | WO2004044174A3 Topoisomerase-targeting agents |
08/12/2004 | WO2004043392A3 Mucin synthesis inhibitors |
08/12/2004 | WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
08/12/2004 | WO2003092374A3 Pesticidal heterocycles |
08/12/2004 | US20040158071 Novel benzylpiperidine compound |
08/12/2004 | US20040158060 Multistage reaction of carbamazepine with peroxyacetic acid and metal catalyst in solvent and catalytic hydrogenation |
08/12/2004 | US20040157897 Polymorphs of an epothilone analog |
08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
08/12/2004 | US20040157863 Triazolopyrimidines |
08/12/2004 | US20040157844 6-azauracil derivatives as thyroid receptor ligands |
08/12/2004 | US20040157827 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
08/12/2004 | US20040156869 Also 2-substituted quinolines, isoquinolines, pyridoquinolines, pyridoisoquinolines, and pyridoquinazolines; treatment of conditions responsive to capsaicin receptor modulation, especially various kinds of pain |
08/12/2004 | DE10304055A1 Verfahren zur Herstellung von Ketalen Process for the preparation of ketals |
08/12/2004 | CA2511806A1 Indole-derivative modulators of steroid hormone nuclear receptors |
08/11/2004 | EP1445257A1 Chromene compound |
08/11/2004 | EP1444221A1 Halogenated nitrobutadienes for controlling animal pests |
08/11/2004 | EP1443933A2 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents |
08/11/2004 | EP1109813B1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists |
08/11/2004 | EP1042294B1 Heterocyclic cytotoxic agents |
08/11/2004 | EP0937047B1 1-arylphthalazine antagonists of excitatory amino acid receptors |
08/11/2004 | CN1520294A Crystalline anticholinergic, method for its prodn., and use thereof in prdon of drug |
08/11/2004 | CN1519242A Compound of benzopyran category marked by fluorin [*F] as well as preparation method and its application of developing agent for D4 receptor of dopamine |
08/11/2004 | CN1519241A Dehydrogenation 'nudike' alkali and preparation method as well as preparation method for synthesizing 'nudike' alkali |
08/11/2004 | CN1161336C Quinolinecarboxamides as antiviral agents |
08/11/2004 | CN1161334C Nitrogen-containing tegracyclic compounds |
08/10/2004 | US6774133 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides |
08/10/2004 | US6774132 Spirooxindole derivatives that act as analgesics |
08/10/2004 | US6774116 Prodrugs via acylation with cinnamate |
08/05/2004 | WO2004065539A2 Androgen receptor antagonists |
08/05/2004 | WO2004065520A1 Light-emitting device, condensed polycyclic compound used therein and method for producing same |
08/05/2004 | WO2004065379A1 Androgen receptor antagonists |
08/05/2004 | WO2004065366A1 2.4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives |
08/05/2004 | WO2004037169A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
08/05/2004 | WO2003051303A3 The total synthesis of merrilactone a |
08/05/2004 | US20040152920 Preparation of ketals |